Metabolic impact of fructose restriction in obese children
Metabolic impact of fructose restriction in obese children
批准号:
8521268
负责人:
ROBERT H LUSTIG
金额:
$50.14万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-10 至 2015-06-30
关键词:
AdultAfrican AmericanBloodBlood PressureCarbohydratesCaucasiansCaucasoid RaceChildChildhoodClinicCollaborationsComorbidityComplexConsumptionCross-Sectional StudiesDataDiabetes MellitusDietDyslipidemiasEndocrinologyEnzyme-Linked Immunosorbent AssayEpidemicEthnic groupEtiologyExhibitsFatty acid glycerol estersFoodFood IndustryFructoseGenderGenesGeneticGlucoseGlucose IntoleranceHealth Care CostsHepaticHigh PrevalenceHyperinsulinismHypertensionImageInsulin ResistanceIntakeInterdisciplinary StudyIntramuscularKineticsLaboratoriesLatinoLeadLinkLipidsLipoproteinsLiverLiver diseasesMagnetic Resonance SpectroscopyMeasurementMeasuresMetabolicMetabolic Clearance RateMetabolic syndromeMetabolismMethodsNitric OxideNon-Insulin-Dependent Diabetes MellitusNutrientNutritionalOGTTObesityOutcomeOutputParticipantPathogenesisPediatricsPhenotypePremature MortalityPrevalencePreventionProductionProtocols documentationPublic HealthRaceRadiology SpecialtyRecording of previous eventsRegulationStagingSymptomsTestingTissuesTriglyceridesUric AcidVariantVisceralblood glucose regulationcohortethnic differenceexperiencefeedingfood marketingglucose disposalimprovedinsulin sensitivityintrahepaticlipid biosynthesislipoprotein lipasenon-alcoholic fatty livernutritionobesity in childrenobesity treatmentracial and ethnicracial/ethnic differencesexstable isotopetranslational studytrendvery low density lipoprotein triglyceride
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The past 30 years have seen a dramatic increase in the proportion of children with from obesity, diabetes, and metabolic syndrome, which drive up health care costs and contribute to premature mortality. The etiology(ies) of metabolic syndrome remain(s) unknown. The racial/ethnic presentations of metabolic syndrome differ, especially in children. Obese Latino children exhibit the highest prevalence of dyslipidemia, visceral adiposity, and non-alcoholic fatty liver disease (NAFLD); African American children present instead with hypertension, worsened insulin resistance, and glucose intolerance.
Understanding these variations in presentation of metabolic syndrome holds the key to understanding its pathogenesis and, therefore, its prevention and treatment. Evidence for both genetic and environmental differences in symptom prevalence abound, and suggest a gene/race-diet interaction.
One likely contributor to the etiology of metabolic syndrome is fructose. The secular trend in fructose consumption parallels the triple epidemics of obesity, type 2 diabetes, and metabolic syndrome in children. Fructose stimulates hepatic de novo lipogenesis, which we have demonstrated contributes to dyslipidemia and NAFLD; and hepatic uric acid synthesis, thought to be important in hypertension.
We hypothesize that racial/ethnic differences in fructose metabolism contribute to the observed racial/ethnic differences in presentation of the metabolic syndrome: that in Latinos, fructose is primarily converted to TG by DNL, which leads to an increase in liver fat content, VLDL-TG output, and TG levels; but in African Americans, a greater proportion of fructose is converted to glucose, which leads to increased glycemia and insulin resistance. We further hypothesize that 10 days of isocaloric fructose restriction will decrease DNL and IHL and improve lipid profiles in Latinos; and improve glucose control, insulin sensitivity, and blood pressure in African Americans.
We will examine insulin sensitivity and glucose disposal (by OGTT), de novo lipogenesis and triglyceride-rich lipoprotein kinetics (by stable isotope measurement), lipid partitioning within tissues (by magnetic resonance spectroscopy), and nitric oxide metabolites (by HLPC and ELISA) in children with metabolic syndrome, stratified by race and gender; and then again after 10 days fructose restriction. We anticipate that comorbidities will improve in a race/ethnic specific fashion. The results of this study will have immediate impact on: 1) reasons for racial/ethnic differences in insulin resistance and obesity; 2) alterations of nutritional information and the Food Pyramid; 3) public health efforts regarding prevention and treatment of obesity, diabetes, and metabolic syndrome around the world; and 4) the regulation of food industry claims and food advertising.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Metabolic impact of fructose restriction in obese children
-
批准号:8309294
-
项目类别:
-
资助金额:$53.53万
-
财政年份:2010
-
负责人:ROBERT H LUSTIG
-
依托单位:
Metabolic impact of fructose restriction in obese children
-
批准号:7950518
-
项目类别:
-
资助金额:$74.18万
-
财政年份:2010
-
负责人:ROBERT H LUSTIG
-
依托单位:
Metabolic impact of fructose restriction in obese children
-
批准号:8142032
-
项目类别:
-
资助金额:$56.38万
-
财政年份:2010
-
负责人:ROBERT H LUSTIG
-
依托单位:
SANDOSTATIN LAR DEPOT VS SALINE-CONTROL IN THE TREATMENT OF HYPOTHALAMIC OBESITY
-
批准号:7204892
-
项目类别:
-
资助金额:$3.19万
-
财政年份:2005
-
负责人:ROBERT H LUSTIG
-
依托单位:
Sandostatin LAW Depot in Patients with Primary Insulin Hypersecretion
-
批准号:6972268
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2004
-
负责人:ROBERT H LUSTIG
-
依托单位:
Autonomic function and insulin dynamics in childhood obesity
-
批准号:7043566
-
项目类别:
-
资助金额:$4.32万
-
财政年份:2004
-
负责人:ROBERT H LUSTIG
-
依托单位:
PILOT STUDY OF THE USE OF OCTREOTIDE IN REDUCING WEIGHT GAIN
-
批准号:6219764
-
项目类别:
-
资助金额:$1.63万
-
财政年份:1999
-
负责人:ROBERT H LUSTIG
-
依托单位:
PILOT STUDY OF METFORMIN IN PROMOTING WEIGHT LOSS IN OBESE ADOLESCENTS
-
批准号:6219784
-
项目类别:
-
资助金额:$1.63万
-
财政年份:1999
-
负责人:ROBERT H LUSTIG
-
依托单位:
PILOT STUDY: OCTREOTIDE IN PROMOTING WEIGHT LOSS IN SERIOUS OBESITY
-
批准号:6264755
-
项目类别:
-
资助金额:$1.63万
-
财政年份:1999
-
负责人:ROBERT H LUSTIG
-
依托单位:
PILOT STUDY OF THE USE OF OCTREOTIDE IN REDUCING WEIGHT GAIN
-
批准号:6116842
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1996
-
负责人:ROBERT H LUSTIG
-
依托单位:
PILOT STUDY OF METFORMIN IN PROMOTING WEIGHT LOSS IN OBESE ADOLESCENTS
-
批准号:6116847
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1996
-
负责人:ROBERT H LUSTIG
-
依托单位:
CRITICAL ANALYSIS OF 16ALPHA-OH-ESTRONE IN BREAST CANCER
-
批准号:3509635
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1992
-
负责人:ROBERT H LUSTIG
-
依托单位:
NEUROENDOCRINE MANIFESTATIONS OF BRAIN IN PEPTIDE
-
批准号:3081293
-
项目类别:
-
资助金额:$5.81万
-
财政年份:1987
-
负责人:ROBERT H LUSTIG
-
依托单位:
NEUROENDOCRINE MANIFESTATIONS OF BRAIN IN PEPTIDE
-
批准号:3081294
-
项目类别:
-
资助金额:$6.14万
-
财政年份:1987
-
负责人:ROBERT H LUSTIG
-
依托单位:
BRAIN PEPTIDE AND SEX STEROID METABOLISM
-
批准号:3081295
-
项目类别:
-
资助金额:$6.48万
-
财政年份:1987
-
负责人:ROBERT H LUSTIG
-
依托单位:
海外基金